Prometheus Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Prometheus Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 509% to $6,809,000. Profit margin reached -2082%. Total operating expenses were $152,587,000.
Profit Margin
| 2016 | 0 | -103.63M | |
|---|---|---|---|
| 2019 | 1.11M | -30.49M | -2727.46% |
| 2022 | 6.80M | -141.75M | -2081.83% |
RXDX Income Statement (2017 – 2023)
| 2023 | 2020 | 2017 | |
|---|---|---|---|
Revenue | |||
Revenue | 6.80M | 1.11M | 0 |
Cost of revenue | 0 | 0 | 0 |
Gross profit | 6.80M | 1.11M | 0 |
Operating exp. | |||
Research and development | 112.84M | 10.95M | 76.92M |
Selling and marketing | 0 | 0 | 0 |
Total operating expenses | 152.58M | 17.08M | 100.68M |
Operating income | -145.77M | -15.96M | -100.68M |
Other income (expenses), net | 4.02M | -761K | -2.95M |
Income before tax | -141.75M | -16.72M | -103.63M |
Income tax expense | -629K | 13.76M | 259K |
Net income | -141.75M | -30.49M | -103.63M |
Earnings per share | |||
Basic EPS | -3.49 | -1.13 | -2.69 |
Diluted EPS | -3.49 | -1.13 | -2.69 |
| Data source | Data source |